Oxytocin ameliorates cisplatin-induced nephrotoxicity in Wistar rats

Annals of Saudi Medicine

Volumn 33, Issue 1, 2013, Pages 57-62

  Elberry, Ahmed A ^a,b   Refaie, Shereen M ^b,c   Kamel, Mohamed ^b   Ali, Tarek ^d   Darwish, Hatem ^d   Ashour, Osama ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b BENI SUEF UNIVERSITY   (Egypt)

^c KING FAISAL UNIVERSITY   (Saudi Arabia)

^d Faculty of Medicine   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CATALASE; CISPLATIN; CREATININE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; LACTATE DEHYDROGENASE; MYELOPEROXIDASE; NITRITE; OXYTOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; KIDNEY INJURY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; CISPLATIN; GLUTATHIONE; KIDNEY; LACTATE DEHYDROGENASES; MALE; NITRIC OXIDE; OXIDATIVE STRESS; OXYTOCIN; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84873913687     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.5144/0256-4947.2013.57     Document Type: Article

References (46)

1. Lebwohl D, Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 1998; 34:1522-34.
2. Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A. Effects of lycopene against cisplatininduced nephrotoxicity and oxidative stress in rats. Toxicol 2005; 212:116-23.
3. Razzaque MS. Cisplatin nephropathy: is cytotoxicity avoidable? Nephrol Dial Transplant 2007; 22:2112-6.
4. Chang BJ, Nishikawa M, Sato E, Utsumi K, Inouea M. L-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine. Arch Biochem Biophys 2002; 405:55-64.
5. Safirstein R, Miller P, Dikman S, Lyman N, Shapiro C. Cisplatin nephrotoxicity in rats: defect in papillary hypertonicity. Am J Physiol 1981; 241:F175-F185.
6. Zhong LF, Zhang JG, Zhang M, Ma SL, Xia YX . Protection against cisplatin-induced lipid peroxidation and kidney damage by procaine in rats. Arch Toxicol 1990; 64:599-600.
7. Badary OA, Abdel-Maksoud S, Ahmed WA, Owieda GH. Naringenin attenuates cisplatin nephrotoxicity in rats. Life Sci 2005; 76:2125-35.
8. Ajith TA, Usha S, Nivitha V. Ascorbic acid and ?-tocopherol protect anticancer drug cisplatininduced nephrotoxicity in mice. A comparative study. Clin Chem Acta 2007; 375:82-6.
9. Hanigen MH, Devarajan P. Cisplatin nephrotoxicity: Molecular mechanisms. Cancer Ther 2003; 1:47-61.
10. Barberis C, Mouillac B, Durroux T. Structural bases of vasopressin/oxytocin receptor function. J Endocrinol 1998; 156:223-9.
11. Olson BR, Hoffman GE, Sved AF, Stricker EM, Verbalis JG. Cholecystokinin induces c-fos expression in hypothalamic oxytocinergic neurons projecting to the dorsal vagal complex. Brain Res 1992; 569:238-48.
12. Jankowski M, Wang D, Hajjar F, Mukaddam- Daher S, McCann SM, Gutkowska J. Oxytocin and its receptors are synthesized in the rat vasculature. Proc Natl Acad Sci USA 2000; 97:6207-11.
13. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function and regulation. Physiol Rev 2001; 81:629-33.
14. Houshmand F, Faghihi M, Zahediasl S. Biphasic protective effect of oxytocin on cardiac ischemia/reperfusion injury in anaesthetized rats. Peptides 2009; 30:2301-8.
15. Moosman B, Behl C. Secretory peptide hormones are biochemical antioxidants; structure- activity relationship. Mol Pharmacol 2002; 61:260-8.
16. Rashed LA, Hashem RM, Soliman HM. Oxytocin inhibits NADPH oxidase and P38 MAPK in cisplatin-induced nephrotoxicity. Biomed Pharmacother 2011; 65: 474-480.
17. Dü?ünceli F, Iseri S, Ercan F, Gedik N, Yegen C, Yegen B. Oxytocin alleviates hepatic ischemia-reperfusion injury in rats. Peptides 2008; 29:1216-22.
18. Doumas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin with bromocresol green. Clin Chim Acta 1971; 31:87-96.
19. Martinek RG. A rapid ultraviolent spectrophotometric lactic dehydrogenase assay. Clin Chem Acta 1972; 40:91-9.
20. Talke H, Schubert GE Enzymatic urea determination in the blood and serum in the Warburg optical test. Klin Wochenschr 1965; 43:174-5.
21. Slot C. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 1965; 17: 381-7.
22. Moron MA, Depicrre JW, Mannervick K. Levels of glutathione and glutathione-S-transferase activities in rat liver. Biochem Biophys Acta 1979; 582:67-8.
23. Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86:271-8.
24. Stuehr DJ, Know NS, Gross SS. Synthesis of nitrogen oxides from L-arginine by macrophage cytosol: requirement for inducible and constitutive components. Biochem Biophys Res Commun 1989; 161:420-6.
25. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249:7130-39.
26. Aebi H. Catalase in vitro. In: Packer L, Orlando FL (Eds.), Methods in Enzymology. 3rd ed. Academic Press, New York, 1984; pp. 121-6.
27. Kakkar P, Das B, Viswanatham PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984; 21:130-2.
28. Hafeman DG, Sundae RA, Hoekstra WG. Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J Nutr 1974; 104:580-7.
29. Wei H, Frenkel K. In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin. Cancer Res 1991; 51:4443-9.
30. Lowry OH, Rosenbrough NJ, Farr AL, Randall R. Protein determination using Folin-Cicocalteu reagent. J Biol Chem 1951; 193: 265-78.
31. Daugaard G, Abildgaard U. Cisplatin nephrotoxicity. A review. Cancer Chemother Pharmacol 1989; 25:1-9.
32. Townsend DM, Tew KD, He L, King JB, Hanigan MH. Role of glutathione S-transferase Pi in cisplatin- induced nephrotoxicity. Biomed Pharmacother 2009; 63:79-85.
33. Atessahin A, Ceribasi AO, Yuce A, Bulmus O, Cikim G. Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats. Basic Clin Pharmacol Toxicol 2006; 100:121-6.
34. Partibha R, Sameer R, Rataboli PV, Bhiwgade DA, Dhume CY . Enzymatic studies of cisplatininduced oxidative stress in hepatic tissue of rats. Eur J Pharmacol 2006; 532:290-93.
35. Mansour HH, Hafez HF, Fahmy NM. Silymarin modulates cisplatin-induced oxidative stress and hepatotoxicity in rats. J Biochem Mol Biol 2006; 39:656-61.
36. Mansour MA, Mostafa AM, Nagi MN, Khattab MM, Al-Shabanah OA. Protective effect of aminoguanidine against nephrotoxicity induced by cisplatin in normal rats. Comp Biochem Physiol Toxicol Pharmacol 2002; 2:123-28.
37. Al-Majed AA, Sayed-Ahmed A A, Al-Yahya AA, Aleisa AM, Al-Rejaie SS, Al- Shabanah OA. Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine- depleted rat model. Pharmacol Res 2006; 53:278-86.
38. Cetinel S, Hancio?lu S, Sener E, Uner C, Kiliç M, Sener G, et al. Oxytocin treatment alleviates stress-aggravated colitis by a receptor-dependent mechanism. Regul Pept 2010; 160:146-52.
39. Zhang L, Hanigan M.H. Role of cysteine Sconjugate ?-lyase in the metabolism of cisplatin. J Pharmacol Exp Ther 2003; 306:988-994.
40. Sadzuka Y, Shimizu Y, Takino Y, Hirota S. Protection against cisplatin-induced nephrotoxicity in the rat by inducers and an inhibitor of glutathione S-transferase. Biochem Pharmacol 1994; 48:453-459.
41. Rhoden EL, Pereira-Lima L, Rhoden CR, Lucas ML, Teloken C, Bell- Klein A. Role of L-arginine/nitric oxide pathway in renal ischemia-reperfusion in rats. Eur J Surg 2001; 167:224-8.
42. Srivastava RC, Farookh A, Ahmad N, Misra M, Hasan SK, Husain MM. Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats. Biometals 1996; 9:139-42.
43. Saleh S, El-Demerdash E. Protective effects of L-arginine against cisplatininduced renal oxidative stress and toxicity: role of nitric oxide. Basic Clin Pharmacol Toxicol 2005; 97:91-7.
44. Iseri SÖ, Sener G, Saglam B, Gedik N, Ercan F, Yegen BC. Oxytocin ameliorates oxidative colonic inflammation by a neutrophil-dependent mechanism. Peptides 2005; 26:483-91.
45. Biyikli NK, Tu?tepe H, Sener G, Velio?lu-O?ünç A, Cetinel S, Midillio?lu S, et al. Oxytocin alleviates oxidative renal injury in pyelonephritic rats via a neutrophil-dependent mechanism. Peptides 2006; 27:2249-57.
46. Iseri SÖ, Sener G, Saglam B, Gedik N, Ercan F, Yegen BC. Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils. J Surg Res 2005; 126:73-81.